InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: flipper44 post# 71380

Saturday, 08/27/2016 2:54:29 AM

Saturday, August 27, 2016 2:54:29 AM

Post# of 721065
Flip. I think your calculations are probably quite accurate in relation to PFS. The question I ask, is how much importance will NWBO attach to the secondary endpoint of OS? We could still be some way off reaching a median OS calculation. Control arm crossing over to treatment will allow a measurement Of L effectiveness in recurrent GBM. I really don't know if they can unblind the PFS data and go public with it, while still continuing the trial to further accrue OS data.

Thoughts?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News